Skip to main content
. 2016 Jul 11;7(34):55276–55289. doi: 10.18632/oncotarget.10527

Table 4. CD171 Expression in 2224 Epithelial Tumors.

Tumor Type Positive / All (%)
Ovary, serous carcinoma 84 / 97 86.6
Malignant mesothelioma 128 / 183 69.9
Testis, embryonal carcinoma 21 / 35 60.0
Colorectum, adenocarcinoma 118 / 210 56.2
Gingiva, squamous cell carcinoma 20 / 43 46.5
Tongue, squamous cell carcinoma 18 / 39 46.2
Uterus, endometrial cancer 32 / 97 33.0
Stomach, adenocarcinoma 31 / 101 30.7
Liver, cholangiocellular carcinoma 5 / 20 25.0
Renal cell carcinoma/ oncocytoma 71 / 333 21.3
Breast, ductal carcinoma 47 / 231 20.3
Urinary tract, urothelial Carcinoma 17 / 92 18.5
Lung, squamous cell carcinoma 8 / 53 15.1
Testis, seminoma 10 / 71 14.1
Adrenocortical gland, adrenocortical cancer 4 / 31 12.9
Tonsil, squamous cell carcinoma 5 / 41 12.2
Lung, adenocarcinoma 4 / 52 7.7
Salivery gland, pleomprphic adenoma 7 / 114 6.1
Thyroid gland, papillary carcinoma 3 / 58 5.2
Thymus, thymoma 3 / 62 4.8
Prostate, adenocarcinoma 2 / 108 1.9
Liver, hepatocellular carcinoma 1 / 92 1.1
Testis, yolk sac tumor 0 / 3 0.0
Breast, lobular carcinoma 0 / 58 0.0